Impairment of blood rheology by cholestatic jaundice in human beings

Journal of Laboratory and Clinical Medicine

Volumn 142, Issue 6, 2003, Pages 391-398

  Mark, Michael ^b   Walter, Roland ^b   Contesse, John ^b   Reinhart, Walter H ^a  

^a KANTONSSPITAL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BILIRUBIN; BILIRUBIN GLUCURONIDE; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; FIBRINOGEN; LITHOCHOLIC ACID;

ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ERYTHROCYTE SHAPE; ERYTHROCYTE STRUCTURE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; OBSTRUCTIVE JAUNDICE; PLASMA VISCOSITY; SHEAR RATE;

EID: 0346501892     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(03)00156-2     Document Type: Article

References (39)

1. Hayer M, Piva MT, Sieso V, de Bornier BM. Experimental studies on unconjugated bilirubin binding by human erythrocytes. Clin Chim Acta 1990;186:345-50.
2. Wennberg RP. The importance of free bilirubin acid salt in bilirubin uptake by erythrocytes and mitochondria. Pediatr Res 1988;23:443-7.
3. Kaul R, Bajpai VK, Shipstone AC, Kaul HK, Krishna Murti CR. Bilirubin-induced erythrocyte membrane cytotoxicity. Exp Mol Pathol 1981;34:290-8.
4. Bratlid D. Bilirubin binding by human erythrocytes. Scand J Clin Lab Invest 1972;29:91-7.
5. Chen LX, Lu JF, Wang K. The influence of bilirubin on fluidity and rotational correlation times of human erythrocyte membrane. Cell Biol Int Rep 1992;16:567-73.
6. Sato H, Aono S, Semba R, Kashiwamata S. Interaction of bilirubin with human erythrocyte membranes. Bilirubin binding to neuraminidase-and phospholipase-treated membranes. Biochem J 1987;248:21-6.
7. Sato H, Kashiwamata S. Interaction of bilirubin with human erythrocyte membranes. Biochem J 1983;210:489-96.
8. Brites D, Silva R, Brito A. Effect of bilirubin on erythrocyte shape and haemolysis, under hypotonie, aggregating or non-aggregating conditions, and correlation with cell age. Scand J Clin Lab Invest 1997;57:337-50.
9. Brito A, Silva RM, Matos DC, da Silva AT, Brites DT. Alterations of erythrocyte morphology and lipid composition by liyperbilirubinemia. Clin Chim Acta 1996;249:149-65.
10. Mireles LC, Lum MA, Dennery PA. Antioxidant and cytotoxic effects of bilirubin on neonatal eythrocytes. Pediatr Res 1999; 45:355-62.
11. Ali MK, Tayyab S. Calcium-induced bilirubin-dependent hemolysis of human erythrocytes. Biochim Biophys Acta 1997;1326: 124-30.
12. Kirschner-Zilber I, Rabizadeh E, Shaklai N. The interaction of hemin and bilirubin with the human red cell membrane. Biochim Biophys Acta 1982;690:20-30.
13. Kawai K, Cowger ML. Effect of bilirubin on ATPase activity of human erythrocyte membranes. Res Commun Chem Pathol Pharmacol 1981;32:123-35.
14. Brito MA, Silva R, Tiribelli C, Brites D. Assessment of bilirubin toxicity to erythrocytes. Implication in neonatal jaundice management. Eur J Clin Invest 2000;30:239-47.
15. Bonillo-Perales A, Muñoz-Hoyos A, Martínez-Morales A, Molina-Carballo A. Uberos-Fernández J, Puertas-Prieto A. Changes in erythrocytic deformability and plasma viscosity in neonatal ictericia. Am J Perinatol 1999;16:421-7.
16. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000;46:1723-7.
17. Fausa O, Gjone E. Serum bile acid concentrations in patients with liver disease. Scand J Gastroenterol 1976;11:537-43.
18. Panini R, Vandelli MA, Leo E, Salvioli G, Cameroni R. The influence of 2-hydroxypropyl-beta-cyclodextrin on the haemolysis induced by bile acids. J Pharm Pharmacol 1996;48:641-4.
19. Salvioli G, Gaetti E, Panini R, Lugli R, Pradelli JM. Different resistance of mammalian red blood cells to hemolysis by bile salts. Lipids 1993;28:999-1003.
20. Martin GP, El-Hariri LM, Marriott C. Bile salt-and lysophosphatidylcholine-induced membrane damage in human erythrocytes. J Pharm Pharmacol 1992;44:646-50.
21. Lowe PJ, Coleman R. Membrane fluidity and bile salt damage. Biochim Biophys Acta 1981;640:55-65.
22. Lee SP, Scott AJ. Dihydrocholesterol-induced gallstones in the rabbit: evidence that bile acids cause gallbladder epithelial injury. Br J Exp Pathol 1979;60:231-8.
23. Deuticke B. Transformation and restoration of biconcave shape of human erythrocytes induced by amphiphilic agents and changes of ionic environment. Biochim Biophys Acta 1968;163: 494-500.
24. Chien S. Biophysical behavior of red cells in suspension. In: Surgenor MDM, editor. The red blood cell. New York, NY: Academic Press; 1975:1031-3.
25. Bessis M. Red cell shapes: an illustrated classification and its rationales. Nouv Rev Fr Hematol 1972;12:721-46.
26. Ferrell JE, Huestis WH. Phosphoinositide metabolism and the morphology of human erythrocyte. J Cell Biol 1984;98:1992-8.
27. Rosenson RS, Shott S, Lu L, Tangney CC. Hypertriglyceridemia and other factors associated with plasma viscosity. Am J Med 2001;110:488-92.
28. Otto C, Richter WO, Schwandt P. Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: evaluation by selective depletion of low-density lipoproteins or fibrinogen. Metabolism 2000;49:810-3.
29. Sheetz MP, Singer SJ. Equilibrium and kinetic effects of drugs on the shape of human erythrocytes. J Cell Biol 1976;70:251.
30. Brito MA, Brondino CD, Moura JJG, Brites D. Effects of bilirubin molecular species on membrane dynamic properties or human erythrocyte membranes: a spin label electron paramagnetic resonance spectroscopy study. Arch Biochem Biophys 2001;387:57-65.
31. Mark M, Walter R, Meredith DO, Reinhart WH. Commercial taxane formulations induce stomatocytosis and increase blood viscosity. Br J Pharmacol 2001;134:1207-14.
32. Reinhart WH, Baerlocher GM, Cerny T, Owen GRh, Meiselman HJ, Beer JH. Ifosfamide-induced stomatocytosis and mesna-induced echinocytosis: influence on biorheological properties of blood. Eur J Haematol 1999;62:223-30.
33. Reinhart WH, Singh-Marchetti M, Straub PW. Influence of erythrocyte shape on suspension viscosities. Eur J Clin Invest 1992;22:38-44.
34. Meiselman HJ. Rheology of shape-transformed human red cells. Biorheology 1978;15:225-37.
35. Würstner D, Pomorski T, Herrmann A, Müller P. Release of phospholipids from erythrocyte membranes by taurocholate is determined by their transbilayer orientation and hydrophobic backbone. Biochemistry 1998;37:17093-103.
36. Sagawa H, Tazuma S, Kajiyama G. Protection against hydrophobic bile salt-induced cell membrane damage by liposomes and hydrophilic bile salts. Am J Physiol 1993;264:G835-9.
37. Ferraris R, Colombatti G, Fiorentini MT, Carosso R, Arossa W, de la Pierre M. Diagnostic value of serum bile acids and routine liver function tests in hepatobiliary diseases: sensitivity, specificity, and predictive value. Dig Dis Sci 1983;28:129-36.
38. Akashi K, Mizuno S, Isaji S. Comparative study of perioperative management of hepatic resection. Dig Dis Sci 2000;45:1988-1995.
39. O'Connor MJ. Mechanical biliary obstruction. A review of the multisystemic consequences of obstructive jaundice and their impact on perioperative morbidity and mortality. Am Surg 1985; 51:245-251.